Name
Päikesevitamiini OÜ
Registry code
14797019
VAT number
EE102186521
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
04.09.2019 (5)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
47911 - Retail sale via mail order houses or via Internet
225 861 €
5 472 €
2%
-
17 465 €
0
Submitted
No tax arrears
31%
7%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Marek Saal 02.03.1974 (50) | 100% - 2 500.00 EUR | Board member | Direct ownership | Founder |
| 2020 30.06.2021 | 2021 21.01.2022 | 2022 30.06.2023 | 2023 30.06.2024 | |
|---|---|---|---|---|
| Total Revenue | 98 765 € | 148 165 € | 205 716 € | 225 861 € |
| Net profit (loss) for the period | 5 730 € | 16 605 € | 12 944 € | 5 472 € |
| Profit Margin | 6% | 11% | 6% | 2% |
| Current Assets | 16 829 € | 43 198 € | 33 505 € | 46 510 € |
| Fixed Assets | - | - | 36 849 € | 27 814 € |
| Total Assets | 16 829 € | 43 198 € | 70 354 € | 74 324 € |
| Current Liabilities | 8 917 € | 22 681 € | 24 076 € | 35 644 € |
| Non Current Liabilities | - | - | 24 910 € | 21 215 € |
| Total Liabilities | - | - | 48 986 € | 56 859 € |
| Share Capital | - | - | - | - |
| Equity | 7 912 € | 20 517 € | 21 368 € | 17 465 € |
| Employees | 0 | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 50 806.27 € | 3 315.37 € | 128.55 € | - |
| 2023 Q4 | 70 601.96 € | 1 222.24 € | 446.55 € | - |
| 2023 Q3 | 46 225.25 € | - | 128.55 € | - |
| 2023 Q2 | 59 681.24 € | 3 770.08 € | 278.25 € | - |
| 2023 Q1 | 41 448.54 € | - | 672.36 € | - |
| 2022 Q4 | 60 190.3 € | 3 507.19 € | 128.55 € | - |
| 2022 Q3 | 48 604.04 € | 1 516.88 € | 128.55 € | - |
| 2022 Q2 | 57 066.52 € | 1 494.36 € | 221.88 € | - |
| 2022 Q1 | 44 548.66 € | 90.45 € | 678.85 € | - |
| 2021 Q4 | 48 813.48 € | 3 614.46 € | - | - |
| 2021 Q3 | 32 067.51 € | - | - | - |
| 2021 Q2 | 31 480.04 € | 1 184.35 € | - | - |
| 2021 Q1 | 34 837.54 € | - | - | - |
| 2020 Q4 | 52 081.42 € | 1 894.9 € | - | - |
| 2020 Q3 | 20 921.05 € | - | - | - |
| 2020 Q2 | 9 363.39 € | 99.12 € | - | - |
| 2020 Q1 | 2 962.92 € | - | - | - |
